AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET (2025 - 2030)

The Automated Breast Ultrasound Systems Market was valued at USD 2.30 billion in 2024 and is projected to reach a market size of USD 5.32 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 15%.

Automatic breast ultrasound systems (ABUS) are advanced imaging equipment used for breast cancer screening. These systems provide standardized, reproducible, and operator-independent imaging. Automated breast ultrasound systems use a high-frequency transducer to generate 3D images of breast tissue. This is especially useful for women with dense breast tissue, where mammography may be less effective. Automated breast ultrasound systems improve the detection of lesions and improve treatment accuracy. This automation reduces variability caused by manual ultrasound processes. The system automatically scans the entire breast and captures multiple views. A radiologist can analyse images more efficiently and with more confidence. Automated breast ultrasound systems are integrated into hospital workflows and diagnostic centers. This supports the early detection and improves the patient's outcome. The system is non-invasive and radiation-free. It increases the patient's comfort and reduces the examination time. Routine screening programs are being adopted rapidly. It complements mammography and other imaging forms. The technology is supported by clinical guidelines and reimbursement policies. Automated breast ultrasound systems are receiving traction due to increasing cases of breast cancer worldwide. It is also driven by awareness campaigns and government initiatives. The system is used in hospitals, imaging centers, and ambulatory surgical units. Automated breast ultrasound systems are evolving with AI-based enhancements and digital integration. It is an important tool in modern breast imaging. The market is expanding with the increasing demand for accurate diagnosis. Automated breast ultrasound systems

Key Market Insights:

• Automated Breast Ultrasound Systems are a dominant technology among imaging modalities due to their standardized imaging and reproducibility, representing around 55-65% market share.
• Application of Automated Breast Ultrasound Systems accounts for 65% of Breast cancer screening, driven by early detection needs.
• Over 2.5 million women were diagnosed with breast cancer globally in 2022. ABUS is preferred for women with dense breast tissue, where mammography sensitivity is limited.
• Almost 50% of hospitals adopted automated breast ultrasound systems supported by infrastructure and reimbursement policies.
• ABUS systems increasingly feature AI-based lesion detection, improving diagnostic confidence and reducing interpretation time.
• Government support programs like the CDC’s National Breast and Cervical Cancer Early Detection Program have screened over 6 million women, accelerating Automated breast ultrasound systems.

Market Drivers:

The primary factor powering the Automated Breast Ultrasound Systems Market is the rising breast cancer prevalence.

Breast cancer cases are increasing globally. This growth is demanding better screening tools. Automated breast ultrasound systems help to detect cancer in dense breast tissue. Mammography alone can miss the early-stage tumour. Automated breast ultrasound systems provide clear images and improve detection rates. Governments and health bodies promote early diagnosis. Awareness programs encourage regular screening. ABUS supports these efforts with reliable imaging. Hospitals and clinics are widely adopting Automated breast ultrasound systems. The system improves clinical confidence. It helps to quickly identify small lesions. It leads to better treatment results. The growing requirement for accurate screening is a major market driver.

Rapid technological advancements and digital health technologies are driving the Automated Breast Ultrasound Systems Market.

Automated breast ultrasound systems are developing with technological advancements. The integration of AI improves image analysis. 3D imaging increases the visibility of the wound. Automatic scanning operator reduces errors. These characteristics improve workflow efficiency. A radiologist can interpret images rapidly and more accurately. Systems now provide better ergonomics and user interfaces. PACS integration supports seamless data sharing. Portable ABUS units expand access to remote areas. Innovation attracts investment from healthcare providers. Companies are regularly launching advanced models. This progress promotes adoption in facilities. Better performance and reliability drive market growth. Technology continues to shape the future of Automated breast ultrasound systems.

Market Restraints and Challenges:

High cost is a major challenge in adopting the automated breast ultrasound systems. Early investment and maintenance expenses are important. Small clinics can struggle to bear the system. The lack of skilled professionals further limits the usage of this system. Training is required to conduct and interpret the results of the Automated Breast Ultrasound System. Regulatory approval can delay product launch. Reimbursement policies vary in different areas. Some countries lack structured screening programs. Patient awareness in developing areas is still low. Integration with existing systems can be complex. These factors slow down the market. It is necessary to address cost and training obstacles. Overcoming these challenges will support the widespread adoption of ABUS technology.

Market Opportunities:

Emerging markets provide strong growth potential. Rising healthcare investments support the adoption. Governments are expanding cancer screening programs. The demand for non-invasive diagnostics is increasing. Portable Automated breast ultrasound systems can reach underserved regions. AI integration opens new possibilities. A telehealth platform can use ABUS for remote diagnostics. Public-private partnership can improve access. Awareness campaign is gaining momentum. Hospitals want efficient and accurate equipment. ABUS fits into modern diagnostic workflows. These factors offer strong opportunities for the Automated breast ultrasound systems market expansion.

AUTOMATED BREAST ULTRASOUND SYSTEMS MARKET (2025 - 2030)

Market Segmentation:

Segmentation By Type:

• Automated Breast Volume Scanner
• Automated Breast Ultrasound System
• Others

The automatic breast ultrasound system is the largest segment in the automated breast ultrasound systems market. It is widely used in hospitals and clinical centers. ABUS provides frequent imaging and reduces operator dependence. It is preferred for dense breast tissue screening. The system provides high-resolution 3D images. It supports early cancer detection and improves workflows. Automated breast ultrasound systems are supported by clinical guidelines and reimbursement policies. Its adoption is increasing due to proven clinical accuracy.

The automatic breast volume scanner (ABVS) is the fastest-growing segment in the automated breast ultrasound systems market. It provides full breast volume imaging in a single scan. ABVS improves efficiency and reduces scanning time. It is gaining popularity in advanced screening programs. The system supports better lesion localization. ABVS has been integrated with AI tools for enhanced analysis. It is preferred in high-throughput imaging centers. The increasing demand for fast and accurate diagnosis is increasing. Technological upgrades are increasing their market share.

Segmentation By Application:

• Screening
• Pre-operative Evaluation
• Others

Screening is the largest application in the Automated breast ultrasound systems market. It is used to check for regular breast cancer. Automated breast ultrasound systems are preferred for women with dense breast tissue. Screening programs incorporate automated breast ultrasound systems for better detection. Hospitals and clinics use it for initial diagnosis. It reduces false negatives and improves accuracy. Governments promote screening to reduce mortality. ABUS

 supports large-scale screening. Its role in preventive care makes it prominent and dominating in the Automated breast ultrasound systems market.

Pre-operative evaluation is the fastest-growing application in the Automated breast ultrasound systems market. This helps in planning surgery with accurate imaging. Automated breast ultrasound systems provide a wide view of the size and location of the tumour. Surgeons use it to assess margin and tissue participation. It improves surgical results and reduces complications. The system supports the individual treatment plan. The increasing breast cancer surgeries is increasing the demand for Automated breast ultrasound systems. Automated breast ultrasound systems have been integrated into pre-operative workflows. Its clinical value is driving ABUS adoption rapidly.

Segmentation By End-User:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Hospitals are the largest end-user segment in the Automated breast ultrasound systems market. They have an infrastructure for ABUS. Hospitals operate large versions of breast screening. They follow the structured clinical protocol. ABUS fits into hospital imaging workflows. It supports the early detection and treatment planning. Hospitals invest in advanced imaging tools. The reimbursement policies are in favour of hospital-based diagnosis. Hospitals are the dominant end user of the Automated breast ultrasound systems with their large-scale service and resources.

Diagnostic imaging centers are the fastest-growing segment in the Automated breast ultrasound systems market. They are experts in imaging services and quickly adopt Automated breast ultrasound systems. These centers provide breast screening as a main service. ABUS improves its clinical abilities. This helps to attract patients who receive accurate results. Imaging centers focus on efficiency and speed. ABUS supports high patient throughput. The demand for outpatient diagnostics is increasing. Their flexibility and focus expand rapidly.

Market Segmentation: Regional Analysis:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

North America is the dominating region in the automated breast ultrasound systems market. It has an advanced healthcare infrastructure. Breast cancer awareness is high in this region. Screening programs are well installed. ABUS adoption is supported by reimbursement policies in North America. Leading companies of the automated breast ultrasound systems market are located in the North America region North America. Hospitals and clinics invest in new technologies. Regulatory approvals are streamlined in this region. The North America region leads this market with clinical innovation.

Asia-Pacific is the fastest-growing region in the automated breast ultrasound systems market. The investment in healthcare expenditure is increasing across the country. Governments promote cancer screening programs. Awareness about breast health is increasing. Automated breast ultrasound systems adoption is expanding in urban centers. Portable systems reach remote areas. Local manufacturers enter the market. Demand for accurate diagnosis is increasing. Asia-Pacific shows strong potential for future development.

COVID-19 Impact Analysis:

The epidemic disrupted healthcare services globally. Screening for breast cancer was delayed or cancelled. Automated breast ultrasound systems supported remote diagnosis during lockdown. High-resolution imaging enabled virtual consultation. Demand for contactless and automated equipment increased. Hospitals preferred skilled and safe screening methods. Automated breast ultrasound systems helped reduce patient contact and examination time. Telehealth Integration promoted the use of ABUS. The supply chain disruption affects equipment availability. Recovery efforts revived screening programs. Post-pandemic, ABUS adoption accelerated with increasing demand. The crisis highlighted the need for a reliable diagnosis. ABUS proved valuable in maintaining the continuity of care.

Latest Trends and Developments:

AI-operated Automated breast ultrasound systems are gaining popularity. These devices increase image interpretation and accuracy. Portable ABUS units are being launched for remote use. Companies are investing in ergonomic designs. Integration with cloud platforms supports data sharing. Automated breast ultrasound systems are now used in pre-operative planning. Screening programs include Automated breast ultrasound systems for dense breast tissue. Regulatory approvals are expanding globally. Tech firms run innovation in collaboration. ABUS is being integrated with other imaging modalities. Research focuses on improving image resolution. Hospitals prefer systems that reduce scanning time. These trends reflect the increasing demand for smart and efficient diagnosis.

Key Players in the Market:

• Siemens Healthcare Private Limited
• SuperSonic Imagine
• Koninklijke Philips N.V.
• Lunit Inc.
• SonoCine, Inc.
• CANON MEDICAL SYSTEMS CORPORATION
• TELEMED Medical Systems srl
• Hologic, Inc.
• GE HealthCare.
• Delphinus Medical Technologies, Inc.

Latest Market News:

• March 2025: GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts.The latest Invenia ABUS is designed to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology.